International Journal of Biological Sciences

Impact factor
3.873

ISSN 1449-2288

News feeds of IJBS published articles
My Manuscript
My Account

Journal of Biomedicinenew

Theranostics

International Journal of Medical Sciences

Journal of Cancer

Oncomedicine

Journal of Genomics

Journal of Bone and Joint Infection (JBJI)

Nanotheranostics

Journal of Genomics now in PubMed/PubMed Central. Submit manuscript...

PubMed Central Indexed in Journal Impact Factor

Int J Biol Sci 2013; 9(9):947. doi:10.7150/ijbs.9.947

Erratum

A Novel Aurora-A Inhibitor, BPR1K0609S1, Sensitizes Colorectal Tumor cells to 5-Fluorofracil (5-FU) Treatment

Yoshimi Shionome1, Wen-Hsing Lin2, Hui-Yi Shiao2, Hsing-Pang Hsieh2, John Tsu-An Hsu2, Toru Ouchi1, 3, Corresponding address

1. Department of Medicine, NUHS, Pritzker School of Medicine, The University of Chicago, Evanston, USA.
2. Institute of Biotechnology and Pharmaceutical Research National Health Research Institutes, Miaoli, Taiwan 305.
3. Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, USA.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Shionome Y, Lin WH, Shiao HY, Hsieh HP, Hsu JTA, Ouchi T. A Novel Aurora-A Inhibitor, BPR1K0609S1, Sensitizes Colorectal Tumor cells to 5-Fluorofracil (5-FU) Treatment. Int J Biol Sci 2013; 9(9):947. doi:10.7150/ijbs.9.947. Available from http://www.ijbs.com/v09p0947.htm

Corrected-article in Int J Biol Sci, Volume 9, 403

 

In our above article of Int J Biol Sci 2013; 9(4): 403-411, we would like to clarify that control data using HCT116 and its derivative cells are shared with our PloS ONE paper [1]. Both papers are about the chemosensitivity of cells to several different Aurora-A inhibitors. We are sorry for the confusion.

References

1. Shionome Y, Yan L, Liu S, Saeki T, Ouchi T. Integrity of p53 Associated Pathways Determines Induction of Apoptosis of Tumor Cells Resistant to Aurora-A Kinase Inhibitors. PLoS ONE. 2013;8(1):e55457

Author contact

Corresponding address Corresponding author: Toru Ouchi, Department of Cancer Genetics, Roswell Park Cancer Institute, Elm and Carlson Streets, Buffalo, NY 14263, USA. Phone: (716) 845-7173. Fax: (716) 845-1698 Email: Toru.Ouchiorg.


Published 2013-9-22